Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Fluidigm Corp at Cowen Health Care Conference Transcript

Mar 12, 2019 / 02:40PM GMT
Release Date Price: $12.07 (+3.25%)
Adam Wieschhaus
Cowen and Company - Life Science and Diagnostic Tools

Good morning. My name is Adam Wieschhaus. I'm on the Life Science Diagnostics and Tools team here at Cowen. It's my pleasure to introduce Fluidigm. Presenting for Fluidigm today, we have Chris Linthwaite, the President and CEO.

Chris Linthwaite
Fluidigm Corp - President & CEO

Hopefully, my -- oh, that's worse. Are we back down? Okay. This is better than a town hall meeting that I gave a couple of weeks -- last week, in which there's a reverb going simultaneously that's one of those moments we hear in the same phrase over and over and over again like you're in the Yankee Stadium. I did that for two hours. It drove me nuts. This will not be that way.

So, again, first, thanks opening statement to Cowen for including us in this particular conference. I'm just really excited to show some of the present progress that Fluidigm as a company has made here over the past year. It's quite a difference that a year has made in our company's prospects.

Throughout this presentation,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot